• 생명과학회지
• /
• 제25권1호
• /
• pp.16-20
• /
• 2015

참돔과 감성돔은 우리나라 주변에 서식하는 고유 어종으로, 참돔의 암컷과 감성돔의 수컷을 이용한 인공수정에 의하여 잡종은 생산되었으나, 자연 상태에서는 이들 간의 잡종이 보고된 바 없다. 이들 두 어종의 암수 및 타 어종을 섞어서 대형 수조에서 사육하는 과정에서 생산된 수정란을 회수하여 부화시켜 육성하는 과정에서 이들 두 종간의 잡종의 형태를 보이는 개체들이 관찰되었다. 임의로 96개체를 선택하여 두 종에 모두 적용할 수 있는 microsatellite marker를 이용하여 유전학적 분석을 실시한 결과 96개체 중 두 종의 혼합된 형태적 특징을 보이는 15개체는 참돔 암컷과 감성돔 수컷 간의 잡종으로 판명되었으며, 나머지 81개체는 감성돔 치어로 확인되었다. 사육 수조의 크기가 매우 컸으며 다른 어류들도 함께 들어 있었다는 점과, 이와 같이 유전적으로 구분되는 두 종 간의 잡종이 자연상태와 유사한 환경에서 생산되었다는 점을 고려할 때 본 연구의 결과는 자연 상태에서도 인위적인 영향이나 기후 변화에 의하여 이들의 서식지가 중복될 경우 두 종간의 잡종이 생산될 가능성이 있다는 것을 시사한다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제14권1호
• /
• pp.217-223
• /
• 2013

Background: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, and the outcomes for patients are still poor. It is important to determine the original type of synchronous multinodular HCC for preoperative assessment and the choice of treatment therapy as well as for the prediction of prognosis after treatment. Aims: To analyze clinicopathologic characteristics and prognoses in patients with multicentric occurrence (MO) and intrahepatic metastasis (IM) of synchronous multinodular hepatocellular carcinoma (HCC). Methods: The study group comprised 42 multinodular HCC patients with a total of 112 nodules. The control group comprised 20 HCC patients with 16 single nodular HCC cases and 4 HCC cases with a portal vein tumor emboli. The mitochondrial DNA (mtDNA) D-loop region was sequenced, and the patients of the study group were categorized as MO or IM based on the sequence variations. Univariate and multivariate analyses were used to determine the important clinicopathologic characteristics in the two groups. Results: In the study group, 20 cases were categorized as MO, and 22 as IM, whereas all 20 cases in the control group were characterized as IM. Several factors significantly differed between the IM and MO patients, including hepatitis B e antigen (HBeAg), cumulative tumor size, tumor nodule location, cirrhosis, portal vein and/or microvascular tumor embolus and the histological grade of the primary nodule. Multivariate analysis further demonstrated that cirrhosis and portal vein and/or microvascular tumor thrombus were independent factors differentiating between IM and MO patients. The tumor-free survival time of the MO subjects was significantly longer than that of the IM subjects ($25.7{\pm}4.8$ months vs. $8.9{\pm}3.1$ months, p=0.017). Similarly, the overall survival time of the MO subjects was longer ($31.6{\pm}5.3$ months vs. $15.4{\pm}3.4$ months, p=0.024). The multivariate analysis further demonstrated that the original type (p=0.035) and Child-Pugh grade (p<0.001) were independent predictors of tumor-free survival time. Cirrhosis (p=0.011), original type (p=0.034) and Child-Pugh grade (p<0.001) were independent predictors of overall survival time. Conclusions: HBeAg, cumulative tumor size, tumor nodule location, cirrhosis, portal vein and/or microvascular tumor embolus and histological grade of the primary nodule are important factors for differentiating IM and MO. MO HCC patients might have a favorable outcome compared with IM patients.